Alloresistance to K locus class I-mismatched bone marrow engraftment is mediated entirely by CD4+ and CD8+ T cells

Bone Marrow Transplantation

Volumn 18, Issue 2, 1996, Pages 285-292

  Hayashi, H ^a   LeGuern, C ^a   Sachs, D H ^a   Sykes, M ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Alloresistance; Bone marrow transplantation; Class I MHC; T cells; Tolerance

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; LYMPHOCYTE ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MONOCLONAL ANTIBODY;

ALLOGRAFT; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BONE MARROW TRANSPLANTATION; CHIMERA; CONTROLLED STUDY; FEMALE; GRANULOCYTE; HELPER CELL; HISTOINCOMPATIBILITY; IRRADIATION; LEUKOCYTE DIFFERENTIAL COUNT; LYMPHOCYTE COUNT; MONOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SUPPRESSOR CELL; T LYMPHOCYTE; THYMUS; WHOLE BODY RADIATION;

ANIMALS; BONE MARROW TRANSPLANTATION; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; FEMALE; GENES, MHC CLASS I; IMMUNE TOLERANCE; MICE; MICE, INBRED C57BL;

EID: 0029841926     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Ildstad ST, Sachs DH. Reconstitution with syngeneic plus allogeneic or xenogeneic bone marrow leads to specific acceptance of allografts or xenografts. Nature 1984; 307: 168-170.
2. Kernan NA, Flomenberg N, Dupont B, O'Reilly RJ. Graft rejection in recipients of T-cell-depleted HLA-nonidentical marrow transplants for leukemia. Transplantation 1987; 43: 842-847.
3. Clift RA, Storb R. Histoincompatible bone marrow transplants in humans. Ann Rev Immunol 1987; 5: 43-64.
4. Sykes M, Sachs DH, Nienhuis AW et al Specific prolongation of skin graft survival following retroviral transduction of bone marrow with an allogeneic MHC gene. Transplantation 1993; 55: 197-202.
5. Fraser CC, Sykes M, Lee RS et al. Specific unresponsiveness to a retrovirally-transferred class I antigen is controlled through the helper pathway. J Immunol 1995; 154: 1587-1595.
6. Sharabi Y, Sachs DH. Mixed chimerism and permanent specific transplantation tolerance induced by a non-lethal preparative regimen. J Exp Med 1989; 169: 493-502.
7. Morse HC, Shen FW, Hammerling U. Genetic nomenclature for loci controlling mouse lymphocyte antigens. Immunogenetics 1987; 25: 71-78.
8. + T cell activity. J Immunol 1993; 150: 197-205.
9. Dialynas DP, Quan ZS, Wall KA et al. Characterization of murine T cell surface molecule, designated L3T4, identified by monoclonal antibody GK 1.5: similarity of L3T4 to human Leu3/T4 molecule. J Immunol 1983; 131: 2445-2451.
10. Sarmiento M, Glasebrook AL, Fitch FW. IgG or IgM monoclonal antibodies reactive with different determinants on the molecular complex bearing Lyt2 antigen block T cell-mediated cytolysis in the absence of complement. J Immunol 1980; 125: 2665-2670.
11. Ozato K, Mayer NM, Sachs DH. Monoclonal antibodies to mouse major histocompatibility complex antigens IV. A series of hybridoma clones producing anti-H-2d antibodies and an examination of expression of H-2d antigens on the surface of these cells. Transplantation 1982; 34: 113-120.
12. Ildstad ST, Wren SM, Bluestone JA et al. Characterization of mixed allogeneic chimeras. Immunocompetence, in vitro reactivity, and genetic specificity of tolerance. J Exp Med 1985; 162: 231-244.
13. Sharabi Y, Sachs DH, Sykes M. T cell subsets resisting induction of mixed chimerism across various histocompatibility barriers. Proc 8th Intl Cong Immunol, Budapest, August 1992, 1992; 801-805.
14. Sykes M, Chester CH, Sundt TM et al. Effects of T cell depletion in radiation bone marrow chimeras: III. Characterization of allogeneic bone marrow cell populations that increase allogeneic chimerism independently of graft-vs-host disease in mixed marrow recipients. J Immunol 1989; 143: 3503-3511.
15. Tomita Y, Sachs DH, Sykes M. Myelosuppressive conditioning is required to achieve engraftment of pluripotent stem cells contained in moderate doses of syngeneic bone marrow. Blood 1994; 83: 939-948.
16. Brecher G, Ansell JD, Micklem HS et al. Special proliferative sites are not needed for seeding and proliferation of transfused bone marrow cells in normal syngeneic mice. Proc Natl Acad Sci USA 1982; 79: 5085-5087.
17. Stewart FM, Crittenden RB, Lowry PA et al. Long-term engraftment of normal and post-5-fluorouracil murine marrow into normal nonmyeloablated mice. Blood 1993; 81: 2566-2571.
18. Smith LG, Weissman Irving L, Heimfeld S. Clonal analysis of hematopoietic stem-cell differentiation in vivo. Proc Natl Acad Sci USA 1991; 88: 2788-2792.
19. Vallera DA, Taylor PA, Sprent J, Blazar BR. The role of host T cell subsets in bone marrow rejection directed to isolated major histocompatibility complex class I versus class II differences of bm1 and bm12 mutant mice. Transplantation 1994; 57: 249-256.
20. Murphy WJ, Kumar V, Bennett M. Acute rejection of murine bone marrow allografts by natural killer cells and T cells. Differences in kinetics and target antigens recognized. J Exp Med 1987; 166: 1499-1509.
21. Dennert G, Anderson CG, Warner J. T killer cells play a role in allogeneic bone marrow graft rejection but not in hybrid resistance. J Immunol 1985; 135: 3729-3734.
22. Szilvassy S, Cory S. Phenotypic and functional characterization of competitive long-term repopulating hematopoietic stem cells enriched from 5-fluorouracil-treated murine marrow. Blood 1993; 81: 2310-2316.
23. Szilvassy SJ, Fraser CC, Eaves CJ et al. Retrovirus-mediated gene transfer to purified hemopoietic stem cells with long-term lympho-myelopoietic repopulating ability. Proc Natl Acad Sci USA 1989; 86: 8798-8802.
24. Deeg HJ, Huss R. Major histocompatibility complex class II molecules, hemopoiesis and the marrow microenvironment. Bone Marrow Transplant 1993; 12: 425-430.
25. Tomita Y, Khan A, Sykes M. Role of intrathymic clonal deletion and peripheral anergy in transplantation tolerance induced by bone marrow transplantation in mice conditioned with a non-myeloablative regimen. J Immunol 1994; 153: 1087-1098.
26. Tomita Y, Khan A, Sykes M. Mechanism by which additional monoclonal antibody injections overcome the requirement for thymic irradiation to achieve mixed chimerism in mice receiving bone marrow transplantation after conditioning with anti-T cell mAbs and 3 Gy whole body irradiation. Transplantation 1996; 61: 477-485.
27. + cells. J Exp Med 1994; 180: 307-317.
28. Murphy WJ, Kumar V, Bennett M. Rejection of bone marrow allografts by mice with severe combined immune deficiency (scid). Evidence that natural killer cells can mediate the specificity of marrow graft rejection. J Exp Med 1987; 165: 1212-1217.
29. Cudkowicz G, Bennett M. Peculiar immunobiology of bone marrow allografts. I. Graft rejection by irradiated responder mice. J Exp Med 71; 134: 83-102.
30. Yu YYL, Kumar V, Bennett M. Murine natural killer cells and marrow graft rejection. Ann Rev Immunol 1993; 10: 189-213.
31. Kiessling R, Hochman PS, Haller O et al. Evidence for a similar or common mechanism for natural killer activity and resistance to hemopoietic grafts. Eur J Immunol 1977; 7: 655-663.
32. Takeda K, Moore MW, Dennert G. Acute rejection of marrow grafts in mice. Dependence on and independence of functional TCR in the rejection process. J Immunol 1994; 152: 4407-4416.
33. Lee LA, Sergio JJ, Sykes M. Natural killer cells weakly resist engraftment of allogeneic long-term multilineage-repopulating hematopoietic stem cells. Transplantation 1996; 61: 125-132.
34. Bachar-Lustig E, Rachamin N, Li H-W, Lan F, Reisner Y. Megadose of T cell-depleted bone marrow overcomes MHC barriers in sublethally irradiated mice. Nature Med 1995; 1: 1268-1273.